eNOS (NOS3) Human shRNA Plasmid Kit (Locus ID 4846)
Referentie TL320432
Formaat : 1kit
Neem contact op met een lokale distributeur :
eNOS (NOS3) Human shRNA Plasmid Kit (Locus ID 4846)
SKU
TL320432
NOS3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
In Stock*
| Product Data | |
| Locus ID | 4846 |
|---|---|
| Synonyms | ECNOS; eNOS |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol (34 ug/ml) |
| Format | Lentiviral plasmids |
| Components | NOS3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 4846). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
| RefSeq | NM_000603, NM_001160109, NM_001160110, NM_001160111, NM_000603.1, NM_000603.2, NM_000603.3, NM_000603.4, NM_001160109.1, NM_001160110.1, NM_001160111.1, BC063294, BC063294.1, BC069465, NM_000603.5, NM_001160109.2 |
| UniProt ID | P29474 |
| Summary | Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016] |
| shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact tech@clinisciences.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Write Your Own Review
| Product Manuals |
|
| FAQs |
|
| SDS |
| RNAi Resources |
|
Related Products
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.